SEC Form 6-K Summary
Registrant: Flora Growth Corp. The supplied metadata identifies Zerostack Corp., but the filing names Flora Growth Corp. as the registrant.
Reporting period: July 2021; material event effective July 22, 2021. The report was signed July 23, 2021.
Business Context and Material Event
Flora Growth entered into a Second Supplemental Indenture with TSX Trust Company, its warrant agent, amending the warrant indenture governing warrants issued in its December 2020 Regulation A, Tier 2 offering.
- The amendment extends the expiry date by three months for approximately 6.67 million unexercised warrants, on a post-consolidation basis.
- The extended warrants now expire 21 months after their respective issue dates.
- The original offering provided for up to 20 million common share purchase warrants.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It also does not quantify any financial impact from the warrant extension.
Changes Versus Prior Period
The material change disclosed is the three-month extension of the expiry dates of all unexercised warrants issued under the December 2020 Regulation A Offering. No comparable-period financial information is included.
Outlook, Risks, and Unusual Items
The filing contains general forward-looking statement disclaimers. It states that future plans, objectives, events, performance, and related assumptions are subject to significant uncertainties and contingencies beyond the Corporation’s control. No specific operational or financial guidance is provided.
The warrant amendment could affect future warrant exercises and potential common-share issuance, but the filing does not state the expected exercise rate, proceeds, dilution, or accounting impact.
Investor Verification Checklist
- Review the full Second Supplemental Indenture furnished as Exhibit 4.7 for the precise warrant populations and revised expiry dates.
- Confirm the number of outstanding and unexercised warrants and their applicable exercise terms.
- Assess potential dilution and cash proceeds if the extended warrants are exercised.
- Review subsequent filings for warrant exercises, expirations, amendments, or changes in capital structure.
- Reconcile the filing’s registrant, Flora Growth Corp., with the supplied metadata identifying Zerostack Corp.